MedTrace Logo

Project Q Pilot: Smoking Cessation for Light Smokers

NCT03416621 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of an intervention to promote smoking cessation among light smokers.

Conditions

  • Tobacco Use Cessation

Interventions

BEHAVIORAL

Cognitive behavioral cessation counseling

Standard smoking cessation plus support text messages

BEHAVIORAL

Counseling and placebo drug intervention

Enhanced cue exposure treatment (lab-based + interactive SMS texting) + DCS placebo

DRUG

Counseling and active drug intervention

Enhanced cue exposure treatment (lab-based + interactive SMS texting)+ active DCS. In addition to an in-person, screening visit, we will conduct three in-person treatment visits and an in-person follow-up visit.

Sponsors & Collaborators

Principal Investigators

  • Kathryn Pollak, PhD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-17
Primary Completion
2020-02-29
Completion
2020-02-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03416621 on ClinicalTrials.gov